Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Low Dose Radiotherapy and Concurrent SBRT in Combination With PD-1 Inhibitors in Advanced Non-small Cell Lung Cancer (NSCLC) .

NCT05615142 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT05615142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05615142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Low Dose Radiotherapy and Concurrent SBRT in Combination With PD-1 Inhibitors in Advanced Non-small Cell Lung Cancer (NSCLC) .
Lead sponsor
Sichuan University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
December 15, 2021
Completion date
December 31, 2026
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low dose radiotherapy, nsclc, pd-1 inhibitor, stereotactic body radiotherapy